World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 99 8519 8006 833 796 447 40689

Mark J. Millan publications per year

The chart shows the history of publications by Mark J. Millan between 1980 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Mark J. Millan published across 46 years, from 1980 to 2025, averaging 10.5 papers a year. Output peaked at 26 publications in 2002. 2 of the 483 publications appeared in the last two years.

No. of publications
5 10 15 20 25
Bar chart. Horizontal axis: year, 1980 to 2025. Vertical axis: number of publications, 0 to 26. Peak 26 publications in 2002. 1980: 1 publication 1981: 3 publications 1982: 4 publications 1983: 0 publications 1984: 3 publications 1985: 2 publications 1986: 2 publications 1987: 1 publication 1988: 2 publications 1989: 1 publication 1990: 8 publications 1991: 10 publications 1992: 7 publications 1993: 4 publications 1994: 11 publications 1995: 13 publications 1996: 8 publications 1997: 16 publications 1998: 17 publications 1999: 18 publications 2000: 25 publications 2001: 25 publications 2002: 26 publications 2003: 13 publications 2004: 24 publications 2005: 12 publications 2006: 18 publications 2007: 9 publications 2008: 21 publications 2009: 19 publications 2010: 15 publications 2011: 16 publications 2012: 23 publications 2013: 11 publications 2014: 21 publications 2015: 13 publications 2016: 7 publications 2017: 9 publications 2018: 11 publications 2019: 6 publications 2020: 11 publications 2021: 6 publications 2022: 9 publications 2023: 0 publications 2024: 1 publication 2025: 1 publication
1980 2025

483 publications in total across all disciplines

View publications per year as a table
Mark J. Millan: publications per year, 1980 to 2025
Year Publications
1980 1
1981 3
1982 4
1983 0
1984 3
1985 2
1986 2
1987 1
1988 2
1989 1
1990 8
1991 10
1992 7
1993 4
1994 11
1995 13
1996 8
1997 16
1998 17
1999 18
2000 25
2001 25
2002 26
2003 13
2004 24
2005 12
2006 18
2007 9
2008 21
2009 19
2010 15
2011 16
2012 23
2013 11
2014 21
2015 13
2016 7
2017 9
2018 11
2019 6
2020 11
2021 6
2022 9
2023 0
2024 1
2025 1
Total 483
Download as CSV

Mark J. Millan publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Mark J. Millan sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 441–460 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 447 publications — 48th percentile

48% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771 447
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Mark J. Millan D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Mark J. Millan sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 98–99 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 99 D-Index — 58th percentile

58% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668 99
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

Mark J. Millan is affiliated with the University of Glasgow in the United Kingdom. Their research spans multiple fields with a focus on Medicine, Neuroscience, and Biochemistry, Genetics and Molecular Biology. Within these domains, their work primarily explores Cellular and Molecular Neuroscience, Molecular Biology, Pharmacology, Physiology, and Biochemistry.

The scientist's major topics of study revolve around Receptor Mechanisms and Signaling, Neuroscience and Neuropharmacology Research, and the Treatment of Major Depression. Other notable areas include Alzheimer's disease research and treatments, Neurotransmitter Receptor Influence on Behavior, Tryptophan and brain disorders, as well as Neuropeptides and Animal Physiology.

Notable recent papers authored or coauthored by Millan include:

  • Agomelatine for the treatment of generalized anxiety disorder: focus on its distinctive mechanism of action, 2022, Therapeutic Advances in Psychopharmacology
  • Dual-acting agents for improving cognition and real-world function in Alzheimer's disease: Focus on 5-HT6 and D3 receptors as hubs, 2020, Neuropharmacology

Other influential works from related fields include "Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing" published in 2020 in Nature Reviews Drug Discovery, and "Prevention of Psychosis" published in 2020 in JAMA Psychiatry.

Frequent coauthors associated with Millan's research include Clotilde Mannoury la Cour, Ross Jeggo, Per Svenningsson, David J. Watson, and K.C.F. Fone, with multiple collaborations ranging from three to four joint publications each.

The scientist regularly publishes in venues such as the International Journal of Molecular Sciences, Neuroscience Applied, Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature, Nature Reviews Drug Discovery, and JAMA Psychiatry.

Best Publications

  • Descending control of pain.

    Mark J. Millan

  • The induction of pain: an integrative review

    Mark J. Millan

  • Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy

    Mark J. Millan;Yves Agid;Martin Brüne;Edward T. Bullmore

  • The neurobiology and control of anxious states

    Mark J. Millan

  • Brain energy rescue: an emerging therapeutic concept for neurodegenerative disorders of ageing

    Stephen C. Cunnane;Eugenia Trushina;Cecilie Morland;Alessandro Prigione

  • Multi-target strategies for the improved treatment of depressive states: Conceptual foundations and neuronal substrates, drug discovery and therapeutic application.

    Mark J. Millan

  • The Novel Melatonin Agonist Agomelatine (S20098) Is an Antagonist at 5-Hydroxytryptamine2C Receptors, Blockade of Which Enhances the Activity of Frontocortical Dopaminergic and Adrenergic Pathways

    Mark J. Millan;Alain Gobert;Françoise Lejeune;Anne Dekeyne

  • Differential Actions of Antiparkinson Agents at Multiple Classes of Monoaminergic Receptor. I. A Multivariate Analysis of the Binding Profiles of 14 Drugs at 21 Native and Cloned Human Receptor Subtypes

    Mark J. Millan;Lisa Maiofiss;Didier Cussac;Valérie Audinot

  • Altering the course of schizophrenia: progress and perspectives

    Mark J. Millan;Annie Andrieux;George Bartzokis;Kristin Cadenhead

  • Agomelatine, the first melatonergic antidepressant: discovery, characterization and development.

    Christian de Bodinat;Béatrice Guardiola-Lemaitre;Elisabeth Mocaër;Pierre Renard

  • Serotonin2C receptors tonically suppress the activity of mesocortical dopaminergic and adrenergic, but not serotonergic, pathways: A combined dialysis and electrophysiological analysis in the rat

    Alain Gobert;Jean‐Michel Rivet;Françoise Lejeune;Adrian Newman‐Tancredi

  • Promoting the clearance of neurotoxic proteins in neurodegenerative disorders of ageing

    Barry Boland;Wai Haung Yu;Olga Corti;Bertrand Mollereau

  • Prevention of Psychosis: Advances in Detection, Prognosis, and Intervention

    Paolo Fusar-Poli;Gonzalo Salazar de Pablo;Gonzalo Salazar de Pablo;Christoph U. Correll;Andreas Meyer-Lindenberg

  • Improving the Treatment of Schizophrenia: Focus on Serotonin (5-HT)1A Receptors

    Mark J. Millan

  • Negative symptoms of schizophrenia: clinical characteristics, pathophysiological substrates, experimental models and prospects for improved treatment

    Mark J. Millan;Kevin Fone;Thomas Steckler;William P. Horan

  • Signaling at G-protein-coupled serotonin receptors: recent advances and future research directions.

    Mark J Millan;Philippe Marin;Philippe Marin;Joëel Bockaert;Joëel Bockaert;Clotilde Mannoury la Cour

  • Deconstructing vulnerability for psychosis: Meta-analysis of environmental risk factors for psychosis in subjects at ultra high-risk

    P. Fusar-Poli;M. Tantardini;S. De Simone;V. Ramella-Cravaro

  • The role of monoamines in the actions of established and "novel" antidepressant agents: a critical review.

    Mark J. Millan

  • Anxiolytic properties of agomelatine, an antidepressant with melatoninergic and serotonergic properties: role of 5-HT2C receptor blockade

    Mark J. Millan;Mauricette Brocco;Alain Gobert;Anne Dekeyne

  • Reciprocal autoreceptor and heteroreceptor control of serotonergic, dopaminergic and noradrenergic transmission in the frontal cortex: relevance to the actions of antidepressant agents.

    Mark J. Millan;Françoise Lejeune;Alain Gobert

Frequent Co-Authors

Alain P. Gobert
Alain P. Gobert Vanderbilt University Medical Center
Jean A. Boutin
Jean A. Boutin Institut de Recherches Internationales Servier
Berend Olivier
Berend Olivier Utrecht University
Michael Spedding
Michael Spedding DuPont (United States)
Pierre Sokoloff
Pierre Sokoloff Grenoble Alpes University
Joël Bockaert
Joël Bockaert University of Montpellier
Philippe Marin
Philippe Marin University of Montpellier
Jean-Daniel Brion
Jean-Daniel Brion Centre national de la recherche scientifique, CNRS
Per Svenningsson
Per Svenningsson Karolinska Institute

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in medical careers beyond traditional MD programs, a variety of online degrees offer flexible and diverse pathways. Exploring related fields can open doors in healthcare leadership, advanced nursing, and mental health services.

Nurses seeking to specialize in psychiatric care can benefit from online msn pmhnp programs, which prepare graduates for advanced practice roles in mental health. Meanwhile, those interested in the administrative side of healthcare can find rewarding opportunities through healthcare administration degrees. These programs focus on hospital management, policy, and organizational leadership.

Ambitious students looking to advance further may consider a graduate degree, such as the most affordable online mha programs. These programs teach strategic management skills for leading healthcare organizations. For nursing professionals seeking the highest level of clinical expertise, cheap dnp online programs offer a cost-effective way to attain a Doctor of Nursing Practice degree.

Exploring these alternative online degrees can provide more options for entering and advancing in the fast-growing healthcare sector.

Best Scientists Citing Mark J. Millan

Trending Scientists

Recently Published Articles